36.6 F
New York
Wednesday, January 27, 2021

Sanofi/GSK Strikes Deal With UK Government For 60 Million Doses Of COVID-19 Vaccine

Must read

Humanigen [NASDAQ: HGEN] Announces Expansion Of Manufacturing Agreement With Ajinomoto Bio-Pharma

Humanigen Inc revealed that the company has extended the manufacturing agreement with  Ajinomoto BioPharma to support the fill-finish of Lenzilumab. The Lenzilumab is...

Synchrony [NYSE: SYF] Announced To Purchase Allegro Credit

Synchrony Financials revealed that the company entered into a definitive contract to Purchase Allegro Credit. Allegro Credit's customer base and merchant network will...

Vericel Corp [NASDAQ: VCEL] Names Joe Mara As The New CFO

Vericel Corporation revealed that the company has named Joe Mara as the CFO of the company. He has over more than 20 years...

A Paychex [NASDAQ: PAYX] Subsidiary Announces Strategic Collaboration With Zoho Books

SurePayroll, a subsidiary of Paychex company revealed that the company has formed a collaboration with Zoho books. SurePAyroll is a provider of small...

Sanofi [NASDAQ: SNY] and GlaxoSmithKline [NYSE: GSK] today announced a supply deal for up to 60 million doses of COVID-19 vaccine with the UK government. Sanofi has developed a vaccine candidate in partnership with GlaxoSmithKline which is based on recombinant protein-based technology.

Sanofi [NASDAQ: SNY] leads the clinical development and registration of COVID-19 vaccine. Phase 1/2 study is expected to start in September and the phase 3 study expected to start by the end of 2020.

Shares of Sanofi dropped 0.69% and down -0.36 during the trading of Tuesday. During the past 52-weeks of trading, this company’s stock have fluctuated between the low of $37.62 and a high of $55.00. It has return on investment (ROI) of 3.50%.

Sanofi has Gross Margin of 68.00%, an Operating Margin of 16.20%, and Profit Margin of 13.60%. Sanofi’s trading volume is 1.54 million as compared to the average volume of 1.39 million.

On the other sides, GalxoSmithKline PLC has exhibited the change of 1.03% and up +0.42 during the trading of Tuesday. Its trading volume is 4.15 million as compared to the average volume of 3.12 million.

If we look at the profitability, it has return on assets (ROA) of 6.90%, return on investment (ROI) of 14.30%, and return on equity (ROE) of 54.00%. Its Gross Margin is 68.20%, and Operating Margin is 21.50%, and the Profit Margin of 15.30%.

Chair of the UK Government’s Vaccines Taskforce, Kate Bingham, said: “Through this agreement with GSK and Sanofi, the Vaccine Taskforce can add another type of vaccine to the three different types of vaccine we have already secured.”

More articles

Latest article

MGP Ingredients [NASDAQ: MGPI] Announced To Acquire Luxco and Its Affiliate Companies

MGP Ingredients  revealed a definitive contract to purchase Luxco, Inc and its affiliated companies. Luxco is an alcohol beverage company with more than 60...

Conformis [NASDAQ: CFMS] Entered A Non-Exclusive agreement with SITES Medical

Conformis Inc revealed that the company inked a development and supply contract with sites medical. Both of the companies will work together to...

Colliers International [NASDAQ: CIGI] Announces Executive Leadership Changes For Australian Business

Colliers International  reported that the company has named Malcom Tyson as the new Chief Executive Officer. He is appointed as the CEO so...

Korn Ferry [NYSE: KFY] Announces Expansion Of Its Footprint In Russian Market

Korn Fery revealed that the company is expanding its footprint in Russia. Moreover, it is adding a high expertise team of executive search...

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...

Shutterstock [NYSE: SSTK] To Extend Its Agreement With EPA

Shutterstock reported that the company renewed its exclusive contract with the European Pressphoto Agency. The extended contract is to distribute the visual content...